Thiadiazine thione derivatives as anti-leishmanial agents: synthesis, biological evaluation, structure activity relationship, ADMET, molecular docking and molecular dyanamics simulation studies.

During last decades, 3,5-disubstituted-tetrahydro-2H-thiadiazine-2-thione scaffold remains the center of interest due to their ease of preparation, diverse range substituents at N-3 and N-5 positions, and profound biological activities. In the current study, a series of 3,5-disubstituted-tetrahydro-2H-thiadiazine-2-thiones were synthesized in good to excellent yield, and the structure of the compounds were confirmed by various spectroscopic techniques such as FTIR, 1H-NMR, 13C-NMR and Mass spectrometry, and finally evaluated against Leishmania major. Whereas, all the evaluated compounds (1-33), demonstrate potential leishmanicidal activities with IC50 values in the range of (1.30- 149.98 uM). Among the evaluated compounds such as 3, 4, 6, and 10 exhibited excellent leishmanicidal activities with IC50 values of (2.17 μM), (2.39 μM), (2.00 μM), and (1.39 μM), respectively even better than the standard amphotericin B (IC50 = 0.50) and pentamidine (IC50 = 7.52). In order to investigate binding interaction of the most active compounds, molecular docking study was conducted with Leishmania major. Further molecular dynamic simulation study was also carried out to assess the stability and correct binding of the most active compound 10, within active site of the Leishamania major. Likewise, the physiochemical properties, drug likeness, and ADMET of the most active compounds were investigated, it was found that none of the compounds violate Lipiniski's rule of five, which show that this class of compounds had enough potential to be used as drug candidate in near future.Communicated by Ramaswamy H. Sarma.

[1]  J. Igoli,et al.  Screening of traditional medicinal plant extracts and compounds identifies a potent anti-leishmanial diarylheptanoid from Siphonochilus aethiopicus , 2023, Journal of biomolecular structure & dynamics.

[2]  A. Cao,et al.  The Appropriate Particle Size of Dazomet Can Ensure the Soil Fumigation Effect from the Source , 2022, Agriculture.

[3]  Nevin Süleymanoğlu,et al.  Bis-1,2,4-triazol derivatives: Synthesis, characterization, DFT, antileishmanial activity and molecular docking study , 2022, Journal of biomolecular structure & dynamics.

[4]  Arabinda Ghosh,et al.  Leishmanicidal and cytotoxic activity of essential oil from the fruit peel of Myrciaria floribunda (H. West ex Willd.) O. Berg: Molecular docking and molecular dynamics simulations of its major constituent onto Leishmania enzyme targets , 2021, Journal of biomolecular structure & dynamics.

[5]  V. Ghule,et al.  1,2,3-Triazoles of 8-Hydroxyquinoline and HBT: Synthesis and Studies (DNA Binding, Antimicrobial, Molecular Docking, ADME, and DFT) , 2021, ACS omega.

[6]  F. H. Leite,et al.  Thermal shift assays of marine-derived fungal metabolites from Aspergillus fischeri MMERU 23 against Leishmania major pteridine reductase 1 and molecular dynamics studies , 2021, Journal of biomolecular structure & dynamics.

[7]  B. Khade,et al.  Synthesis of diverse (E)‐2‐((1 H ‐imidazol‐1‐yl)methyl)‐2‐((benzyloxy)methyl)‐2,3‐dihydro‐1 H ‐inden‐1‐one O‐benzyl oxime derivatives as potent antileishmanial agents , 2020, Journal of Heterocyclic Chemistry.

[8]  A. Wadood,et al.  Synthesis, in vitro urease inhibitory activity and molecular docking of 3,5‐disubstituted thiadiazine‐2‐thiones , 2019, Journal of Heterocyclic Chemistry.

[9]  Terry K. Smith,et al.  Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents , 2019, Bioorganic chemistry.

[10]  Muhammad Ali Minhas,et al.  New series of 3,5-disubstituted tetrahydro-2H-1,3,5-thiadiazine thione (THTT) derivatives: Synthesis and potent antileishmanial activity. , 2018, Bioorganic & medicinal chemistry letters.

[11]  M. Abounassif,et al.  Study of Interactions of an Anticancer Drug Neratinib With Bovine Serum Albumin: Spectroscopic and Molecular Docking Approach , 2018, Front. Chem..

[12]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[13]  P. Michels,et al.  Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds. , 2015, Bioorganic & medicinal chemistry letters.

[14]  S. Gibbons,et al.  Fruitful decade for antileishmanial compounds from 2002 to late 2011. , 2014, Chemical reviews.

[15]  J. Cano,et al.  Leishmaniasis Worldwide and Global Estimates of Its Incidence , 2012, PloS one.

[16]  A. Chattopadhyay,et al.  A novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis. , 2011, Biochemical and biophysical research communications.

[17]  J. Alvar,et al.  Leishmaniasis impact and treatment access. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  Anton J. Hopfinger,et al.  4D-QSAR: Perspectives in Drug Design , 2010, Molecules.

[19]  B. Zagrovic,et al.  Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors. , 2010, Biophysical journal.

[20]  M. Waring Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability. , 2009, Bioorganic & medicinal chemistry letters.

[21]  V. Yardley,et al.  Synthesis and Antiprotozoal Evaluation of New N4‐(Benzyl)spermidyl‐linked bis(1,3,5‐thiadiazinane‐2‐thiones) , 2008, Archiv der Pharmazie.

[22]  R. Peeling,et al.  Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? , 2007, Nature Reviews Microbiology.

[23]  S. Croft,et al.  Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[24]  Adam R Renslo,et al.  Drug discovery and development for neglected parasitic diseases , 2006, Nature chemical biology.

[25]  A. Gómez-Barrio,et al.  Synthesis and antiprotozoan evaluation of new alkyl-linked bis(2-thioxo-[1,3,5]thiadiazinan-3-yl) carboxylic acids. , 2005, Bioorganic & medicinal chemistry.

[26]  R. Coler,et al.  Second-generation vaccines against leishmaniasis. , 2005, Trends in parasitology.

[27]  Gert Vriend,et al.  Making optimal use of empirical energy functions: Force‐field parameterization in crystal space , 2004, Proteins.

[28]  P. Desjeux Leishmaniasis: current situation and new perspectives. , 2004, Comparative immunology, microbiology and infectious diseases.

[29]  V. Yardley,et al.  Chemotherapy of leishmaniasis. , 2002, Current pharmaceutical design.

[30]  A. El-Shorbagi Disubstituted tetrahydro-2H-1,3,5-thiadiazine-2-thiones as lipophilic carriers for glutamine and glutamic acid , 2000 .

[31]  P. Olliaro,et al.  A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment. , 1995, The American journal of tropical medicine and hygiene.

[32]  R. Singh,et al.  Fighting against Leishmaniasis: search of alkaloids as future true potential anti-Leishmanial agents. , 2009, Mini reviews in medicinal chemistry.

[33]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[34]  T. Aboul-Fadl,et al.  New prodrug approach for amino acids and amino-acid-like drugs , 1996 .

[35]  A. El-Shorbagi Model for delivery of amines through incorporation into a tetrahydro-2H-1,3,5-thiadiazine-2-thione structure , 1994 .

[36]  G. Dalekos,et al.  Leishmaniasis revisited: Current aspects on epidemiology, diagnosis and treatment , 2015, Journal of translational internal medicine.